Mangalam Drugs and Organics Ltd Share Price

Pharmaceuticals

NSE: MANGALAM Small Cap ISIN: INE584F01014

As on 13 June 2026 at 04:02 IST

₹28.06

+ 0.15

(0.54%)

Sell Buy

Over 1 Month

-9.73%

Over 6 Months

11.33%

Over 1 Year

-66.57%

Over 3 Years

-73.29%

Mangalam Drugs and Organics Ltd Summary

Close ₹27.91

Open ₹28.79

High ₹28.79

Low ₹27.56

Volume 13,712

Net Turnover (in Cr) ₹0.038

52Wk High ₹95

52Wk Low ₹22.80

52Wk High / Low

22.80

Mangalam Drugs and Organics Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹44.18

EPS (TTM) -

Book Value (BV) 65.27

Div. Yield -

P/E (TTM) -1.01

Price/Book Value 0.43

Delivery % 62 %

Face Value 10

Key Ratios

PE Ratio 16.98

PB Ratio 0.79

EV to Sales 0.66

PEG Ratio -0.10

ROA 2.78

ROE 4.76

Debt-Equity 0.70

Net Profit Margin 2.17

Operating Profit Margin 11.41

Mangalam Drugs and Organics Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Total Revenue	318.73	368.69
Total Expenses	313.95	379.77
Profit Before Tax	4.79	-11.07
Profit After Tax	6.72	-9.07
Operating Profit After Depreciation	19.72	2.84

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Fixed Assets	165.43	155.40
Total Non Current Assets	167.44	157.70
Total Current Assets	198.98	176
Total Assets	366.42	333.70
Total Shareholder's Fund	148.98	135.79

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024
Net Cash From Operating Activities	42.59	3.91
Net Cash Used In Investing Activities	-19.47	-11.83
Net Cash Used In Financing Activities	-21.71	5.23

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	318.73	368.69	372.69	451.16	384.70
Total Expenses	313.74	379.75	370.47	423.42	345.18
Profit Before Tax	4.99	-11.06	2.21	27.73	39.52
Profit After Tax	6.92	-9.05	1.27	19.66	27.97
Operating Profit After Depreciation	19.92	2.86	15.17	38.89	48.85

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	158.21	155.04	151.85	140.49	119.30
Total Non Current Assets	160.25	157.36	154.72	143.39	130.19
Total Current Assets	198.99	199.78	203.26	185.03	133.92
Total Assets	359.24	357.14	357.98	328.43	264.11
Total Shareholder's Fund	148.66	142.35	151.96	150.56	130.79

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	42.76	12.17	38.08	25.71	27.55
Net Cash Used In Investing Activities	-19.47	-17.90	-22.17	-27.33	-31.29
Net Cash Used In Financing Activities	-21.71	5.70	-16.82	2.98	2.70

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	67.29	58.38	49.54	57.35	72.78
Total Expenses	72.91	59.92	52.38	61.82	62.88
Profit Before Tax	-13.27	-9.83	-12.47	-12.99	1.64
Profit After Tax	-13.42	-9.84	-7.35	-13.80	0.06
Operating Profit after Depreciation	-5.53	-1.32	-2.81	-4.47	10.37

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	67.29	58.38	49.54	57.35	72.78
Total Expenses	72.65	59.95	52.38	61.85	62.88
Profit Before Tax	-12.91	-9.77	-12.37	-12.92	1.73
Profit After Tax	-13.06	-9.78	-7.25	-13.73	0.15
Operating Profit after Depreciation	-5.27	-1.35	-2.81	-4.50	10.37

Mangalam Drugs and Organics Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 27.38

S2 26.86

S3 26.15

Pivot 28.09

R1 28.61

R2 29.32

R3 29.84

Moving Average

20 SMA 29.12

50 SMA 29.40

100 SMA 32.17

200 SMA 43.97

Mangalam Drugs and Organics Ltd Corporate Actions

No available data

AGM Date: 24 Sep 2021

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith copies of newspaper advertisement published on September 3, 2021 in Free Press Journal (English daily) and Navshakti (Marathi daily), Mumbai editions, in which Notice of 48th Annual General Meeting scheduled to be held on Friday, September 24, 2021 at 3:30 P.M. (IST) through Video Conferencing/ Other Audio Visual Means and Information on E-voting have been published. Voting results under Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 along with the Scrutinizers Report (As Per BSE Announcement Dated on 9/26/2021 3:52:57 AM) Mangalam Drugs & Organics Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Appointment of V.S. Somani & Co., Chartered Accountants (FRN - 117589W) as the Statutory Auditors of the Company for a term of five consecutive years from the conclusion of the 48th Annual General Meeting till the conclusion of the 53rd Annual General Meeting. Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- 1. Appointment of Shri Praveen Saxena (DIN: 03199264) as a Non-Executive Independent Director of the Company for term of 5 years with effect from March 21, 2021 till March 20, 2026; 2. Re-appointment of Shri Brijmohan M. Dhoot (DIN:01046420) as a Whole-time Director of the Company for term of 3 years w.e.f. August 14, 2021 till August 13, 2024 who has attained the age of seventy years. (As per BSE Announcement Dated on 27/09/2021)

AGM Date: 28 Sep 2022

AGM 28/09/2022 We wish to inform you that the 49th Annual General Meeting ('the AGM') of the Members of the Company will be held on Wednesday, September 28, 2022 at 3:00 P.M. (IST) through Video Conferencing ('VC') or Other Audio-Visual Means ('OAVM') in compliance with Ministry of Corporate Affairs Circulars / the Securities and Exchange Board of India Circulars. Pursuant to Regulation 30 read together with Clause 12 of Part A of Schedule III to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') and Regulation 34(1) of the Listing Regulations, please find enclosed Notice convening 49th Annual General Meeting and Annual Report 2021-22 of the Company which is also being sent only to those Members whose email addresses are registered with the Company/ Depository Participant(s) through electronic mode in accordance with aforesaid Circulars for your records. (As Per BSE Announcement dated on 02.09.2022) Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith copies of newspaper advertisement published on September 3, 2022 in Free Press Journal (English daily) and Navshakti (Marathi daily), in which the Notice of 49th (Forty Nineth) Annual General Meeting of the Company, scheduled to be held on Wednesday, September 28, 2022 at 3:00 P.M. (IST) through Video Conferencing/ Other Audio Visual Means and Information on E-voting have been published. (As per BSE Announcement Dated on 3/9/2022) With respect to captioned subject and mentioned reference, please find enclosed herewith the proceedings of the (49th) Forty Ninth Annual General Meeting of the Company held on September 28, 2022. Voting Results and Scrutinizer's Report as per the requirement of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is also annexed hereto and marked as Annexure - A and Annexure - B respectively. (As Per BSE Announcement Dated on 29/09/2022)

AGM Date: 29 Sep 2023

AGM 29/09/2023 Newspaper publication for notice of AGM (As Per BSE Announcement dated on 07.09.2023) With reference to the captioned subject please find attached the proceedings of the 50th Annual General Meeting of the Company (As per BSE Announcement Dated on 30/09/2023) Report under Regulation 44 along with Scrutinizer''s Report (As Per BSE Announcement Dated on 03/10/2023)

AGM Date: 26 Sep 2024

We wish to inform you that 51st AGM of the Company is scheduled to be held on Thursday, September 26, 2024 at 3:00 P.M. through video conference or other audio visual means, in accordance with the relevant circulars issued by Ministry of Corporate Affairs and SEBI Please find enclosed Annual Report of the Company for the Financial Year 2023-24 including Notice convening the 51st AGM. Voting Results and Scrutinizer''s Report of 51st Annual General Meeting of the Company held on 26th September, 2024 at 3: 00 P.M. (As Per BSE Announcement Dated on 28.09.2024)

AGM Date: 29 Sep 2025

Intimation of 52nd Annual General meeting of the Company to be held on 29th September, 2025 at 3:00 p.m. through video conferencing/ other Audio Visual means. Summary proceedings of the Annual General meeting of Mangalam Drugs and Organics Limited held on 29th September, 2025 t 3:00 p.m. (As Per BSE Announcement Dated on 29.09.2025) Submission of Scrutinizer''s Report along with the Voting results for the resolutions passed by the shareholders of the Company at 52nd Annual General Meeting of the Company held on 29th September, 2025 at 3: 00PM. (As per BSE Announcement dated on: 01.10.2025)

Mangalam Drugs and Organics Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Mangalam Drugs and Organics Ltd Top Mutal Funds Invested

No data available

Mangalam Drugs and Organics Ltd News

Mangalam Drugs and Organics to declare Quarterly Results

On 14 May 2026

07 May 2026, 11:11 am

Mangalam Drugs and Organics to conduct board meeting

On 26 March 2026

25 Mar 2026, 09:45 am

Mangalam Drugs and Organics to declare Quarterly Results

On 6 February 2026

05 Feb 2026, 02:32 pm

Mangalam Drugs and Organics to table results

On 15 January 2026

08 Jan 2026, 09:49 am

Mangalam Drugs and Organics Ltd leads losers in 'B' group

Billionbrains Garage Ventures Ltd, Physicswallah Ltd, Diffusion Engineers Ltd and Anand Rathi Share & Stock Brokers Ltd are among the other losers in the BSE's 'B' group today, 19 November 2025.

19 Nov 2025, 02:45 pm

Mangalam Drugs and Organics Ltd Stock Analysis

Annual revenue for Mangalam Drugs and Organics Ltd decreased by 13.55% to ₹318.73 crore in FY 2025 from ₹368.69 crore in FY 2024.
Annual Net Profit for Mangalam Drugs and Organics Ltd decreased by 176.52% to ₹6.92 crore in FY 2025 from ₹-9.05 crore in FY 2024.
Promoter Shareholding in Mangalam Drugs and Organics Ltd increased by 0.03% in the most recent quarter, from 35.64% in December 2025 to 35.65% in March 2026.
Mangalam Drugs and Organics Ltd delivered a 1-year return of -66.57% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Mangalam Drugs and Organics Ltd share price moved up by 0.54% from its previous close of INR ₹27.91. The latest Mangalam Drugs and Organics Ltd share price is INR ₹28.06.
Mangalam Drugs and Organics Ltd share price today has been at a low of 28.05 and a high of 28.79. Over the past 52 weeks, the Mangalam Drugs and Organics Ltd share price has seen a low of 22.80 and a high of 95.